Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Price Up 1.1% – Here’s What Happened

Shares of Innovator IBD 50 ETF (NYSEARCA:FFTY) traded up 1.1% on Thursday . The stock traded as high as $42.65 and last traded at $42.29. 42,567 shares traded hands during trading, a decline of 44% from the average session volume of 75,524 shares. The stock had previously closed at $41.81.

Innovator IBD 50 ETF Trading Up 1.1%

The company has a market capitalization of $97.27 million, a PE ratio of 30.34 and a beta of 1.47. The firm has a fifty day moving average of $38.00 and a two-hundred day moving average of $37.07.

Institutional Investors Weigh In On Innovator IBD 50 ETF

Several institutional investors have recently bought and sold shares of the stock. Royal Bank of Canada raised its position in Innovator IBD 50 ETF by 3,222.5% during the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after purchasing an additional 17,724 shares during the last quarter. NewEdge Advisors LLC raised its position in Innovator IBD 50 ETF by 48.4% during the 4th quarter. NewEdge Advisors LLC now owns 3,883 shares of the company’s stock valued at $135,000 after purchasing an additional 1,266 shares during the last quarter. Kestra Advisory Services LLC bought a new position in Innovator IBD 50 ETF during the 4th quarter valued at approximately $72,000. Jane Street Group LLC bought a new position in Innovator IBD 50 ETF during the 4th quarter valued at approximately $282,000. Finally, HRT Financial LP bought a new position in Innovator IBD 50 ETF during the 4th quarter valued at approximately $507,000.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.